Global Anti-tumor Drug Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Global Anti-tumor Drug Market 2024 by Company, Regions, Type and Application, Forecast to 2030

Table of Contents

1 Market Overview
1.1 Product Overview and Scope of Anti-tumor Drug
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Anti-tumor Drug by Type
1.3.1 Overview: Global Anti-tumor Drug Market Size by Type: 2019 Versus 2023 Versus 2030
1.3.2 Global Anti-tumor Drug Consumption Value Market Share by Type in 2023
1.3.3 Cytotoxic Drugs
1.3.4 Non-cytotoxic Drugs
1.4 Global Anti-tumor Drug Market by Application
1.4.1 Overview: Global Anti-tumor Drug Market Size by Application: 2019 Versus 2023 Versus 2030
1.4.2 Alkylating Agents
1.4.3 Anti-Metabolism Drugs
1.4.4 Platinum Antineoplastic Agents
1.4.5 Anthracycline Antitumor Drugs
1.4.6 Microtubule Stabilizer
1.4.7 Endocrine Therapy Drugs
1.4.8 Immunotherapy Drugs
1.4.9 Gene Therapy Drugs
1.4.10 Targeted Antineoplastic Drugs
1.5 Global Anti-tumor Drug Market Size & Forecast
1.6 Global Anti-tumor Drug Market Size and Forecast by Region
1.6.1 Global Anti-tumor Drug Market Size by Region: 2019 VS 2023 VS 2030
1.6.2 Global Anti-tumor Drug Market Size by Region, (2019-2030)
1.6.3 North America Anti-tumor Drug Market Size and Prospect (2019-2030)
1.6.4 Europe Anti-tumor Drug Market Size and Prospect (2019-2030)
1.6.5 Asia-Pacific Anti-tumor Drug Market Size and Prospect (2019-2030)
1.6.6 South America Anti-tumor Drug Market Size and Prospect (2019-2030)
1.6.7 Middle East and Africa Anti-tumor Drug Market Size and Prospect (2019-2030)
2 Company Profiles
2.1 Roche
2.1.1 Roche Details
2.1.2 Roche Major Business
2.1.3 Roche Anti-tumor Drug Product and Solutions
2.1.4 Roche Anti-tumor Drug Revenue, Gross Margin and Market Share (2019-2024)
2.1.5 Roche Recent Developments and Future Plans
2.2 Novartis
2.2.1 Novartis Details
2.2.2 Novartis Major Business
2.2.3 Novartis Anti-tumor Drug Product and Solutions
2.2.4 Novartis Anti-tumor Drug Revenue, Gross Margin and Market Share (2019-2024)
2.2.5 Novartis Recent Developments and Future Plans
2.3 Celgene
2.3.1 Celgene Details
2.3.2 Celgene Major Business
2.3.3 Celgene Anti-tumor Drug Product and Solutions
2.3.4 Celgene Anti-tumor Drug Revenue, Gross Margin and Market Share (2019-2024)
2.3.5 Celgene Recent Developments and Future Plans
2.4 Bristol-Myers Squibb
2.4.1 Bristol-Myers Squibb Details
2.4.2 Bristol-Myers Squibb Major Business
2.4.3 Bristol-Myers Squibb Anti-tumor Drug Product and Solutions
2.4.4 Bristol-Myers Squibb Anti-tumor Drug Revenue, Gross Margin and Market Share (2019-2024)
2.4.5 Bristol-Myers Squibb Recent Developments and Future Plans
2.5 Amgen
2.5.1 Amgen Details
2.5.2 Amgen Major Business
2.5.3 Amgen Anti-tumor Drug Product and Solutions
2.5.4 Amgen Anti-tumor Drug Revenue, Gross Margin and Market Share (2019-2024)
2.5.5 Amgen Recent Developments and Future Plans
2.6 Johnson & Johnson
2.6.1 Johnson & Johnson Details
2.6.2 Johnson & Johnson Major Business
2.6.3 Johnson & Johnson Anti-tumor Drug Product and Solutions
2.6.4 Johnson & Johnson Anti-tumor Drug Revenue, Gross Margin and Market Share (2019-2024)
2.6.5 Johnson & Johnson Recent Developments and Future Plans
2.7 Pfizer
2.7.1 Pfizer Details
2.7.2 Pfizer Major Business
2.7.3 Pfizer Anti-tumor Drug Product and Solutions
2.7.4 Pfizer Anti-tumor Drug Revenue, Gross Margin and Market Share (2019-2024)
2.7.5 Pfizer Recent Developments and Future Plans
2.8 Takeda
2.8.1 Takeda Details
2.8.2 Takeda Major Business
2.8.3 Takeda Anti-tumor Drug Product and Solutions
2.8.4 Takeda Anti-tumor Drug Revenue, Gross Margin and Market Share (2019-2024)
2.8.5 Takeda Recent Developments and Future Plans
2.9 Eli Lilly
2.9.1 Eli Lilly Details
2.9.2 Eli Lilly Major Business
2.9.3 Eli Lilly Anti-tumor Drug Product and Solutions
2.9.4 Eli Lilly Anti-tumor Drug Revenue, Gross Margin and Market Share (2019-2024)
2.9.5 Eli Lilly Recent Developments and Future Plans
2.10 AstraZeneca
2.10.1 AstraZeneca Details
2.10.2 AstraZeneca Major Business
2.10.3 AstraZeneca Anti-tumor Drug Product and Solutions
2.10.4 AstraZeneca Anti-tumor Drug Revenue, Gross Margin and Market Share (2019-2024)
2.10.5 AstraZeneca Recent Developments and Future Plans
2.11 Astellas
2.11.1 Astellas Details
2.11.2 Astellas Major Business
2.11.3 Astellas Anti-tumor Drug Product and Solutions
2.11.4 Astellas Anti-tumor Drug Revenue, Gross Margin and Market Share (2019-2024)
2.11.5 Astellas Recent Developments and Future Plans
2.12 Merck & Co
2.12.1 Merck & Co Details
2.12.2 Merck & Co Major Business
2.12.3 Merck & Co Anti-tumor Drug Product and Solutions
2.12.4 Merck & Co Anti-tumor Drug Revenue, Gross Margin and Market Share (2019-2024)
2.12.5 Merck & Co Recent Developments and Future Plans
2.13 Sanofi
2.13.1 Sanofi Details
2.13.2 Sanofi Major Business
2.13.3 Sanofi Anti-tumor Drug Product and Solutions
2.13.4 Sanofi Anti-tumor Drug Revenue, Gross Margin and Market Share (2019-2024)
2.13.5 Sanofi Recent Developments and Future Plans
2.14 Bayer
2.14.1 Bayer Details
2.14.2 Bayer Major Business
2.14.3 Bayer Anti-tumor Drug Product and Solutions
2.14.4 Bayer Anti-tumor Drug Revenue, Gross Margin and Market Share (2019-2024)
2.14.5 Bayer Recent Developments and Future Plans
2.15 Biogen Idec
2.15.1 Biogen Idec Details
2.15.2 Biogen Idec Major Business
2.15.3 Biogen Idec Anti-tumor Drug Product and Solutions
2.15.4 Biogen Idec Anti-tumor Drug Revenue, Gross Margin and Market Share (2019-2024)
2.15.5 Biogen Idec Recent Developments and Future Plans
2.16 Eisai
2.16.1 Eisai Details
2.16.2 Eisai Major Business
2.16.3 Eisai Anti-tumor Drug Product and Solutions
2.16.4 Eisai Anti-tumor Drug Revenue, Gross Margin and Market Share (2019-2024)
2.16.5 Eisai Recent Developments and Future Plans
2.17 Teva
2.17.1 Teva Details
2.17.2 Teva Major Business
2.17.3 Teva Anti-tumor Drug Product and Solutions
2.17.4 Teva Anti-tumor Drug Revenue, Gross Margin and Market Share (2019-2024)
2.17.5 Teva Recent Developments and Future Plans
2.18 Otsuka
2.18.1 Otsuka Details
2.18.2 Otsuka Major Business
2.18.3 Otsuka Anti-tumor Drug Product and Solutions
2.18.4 Otsuka Anti-tumor Drug Revenue, Gross Margin and Market Share (2019-2024)
2.18.5 Otsuka Recent Developments and Future Plans
3 Market Competition, by Players
3.1 Global Anti-tumor Drug Revenue and Share by Players (2019-2024)
3.2 Market Share Analysis (2023)
3.2.1 Market Share of Anti-tumor Drug by Company Revenue
3.2.2 Top 3 Anti-tumor Drug Players Market Share in 2023
3.2.3 Top 6 Anti-tumor Drug Players Market Share in 2023
3.3 Anti-tumor Drug Market: Overall Company Footprint Analysis
3.3.1 Anti-tumor Drug Market: Region Footprint
3.3.2 Anti-tumor Drug Market: Company Product Type Footprint
3.3.3 Anti-tumor Drug Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 Market Size Segment by Type
4.1 Global Anti-tumor Drug Consumption Value and Market Share by Type (2019-2024)
4.2 Global Anti-tumor Drug Market Forecast by Type (2025-2030)
5 Market Size Segment by Application
5.1 Global Anti-tumor Drug Consumption Value Market Share by Application (2019-2024)
5.2 Global Anti-tumor Drug Market Forecast by Application (2025-2030)
6 North America
6.1 North America Anti-tumor Drug Consumption Value by Type (2019-2030)
6.2 North America Anti-tumor Drug Consumption Value by Application (2019-2030)
6.3 North America Anti-tumor Drug Market Size by Country
6.3.1 North America Anti-tumor Drug Consumption Value by Country (2019-2030)
6.3.2 United States Anti-tumor Drug Market Size and Forecast (2019-2030)
6.3.3 Canada Anti-tumor Drug Market Size and Forecast (2019-2030)
6.3.4 Mexico Anti-tumor Drug Market Size and Forecast (2019-2030)
7 Europe
7.1 Europe Anti-tumor Drug Consumption Value by Type (2019-2030)
7.2 Europe Anti-tumor Drug Consumption Value by Application (2019-2030)
7.3 Europe Anti-tumor Drug Market Size by Country
7.3.1 Europe Anti-tumor Drug Consumption Value by Country (2019-2030)
7.3.2 Germany Anti-tumor Drug Market Size and Forecast (2019-2030)
7.3.3 France Anti-tumor Drug Market Size and Forecast (2019-2030)
7.3.4 United Kingdom Anti-tumor Drug Market Size and Forecast (2019-2030)
7.3.5 Russia Anti-tumor Drug Market Size and Forecast (2019-2030)
7.3.6 Italy Anti-tumor Drug Market Size and Forecast (2019-2030)
8 Asia-Pacific
8.1 Asia-Pacific Anti-tumor Drug Consumption Value by Type (2019-2030)
8.2 Asia-Pacific Anti-tumor Drug Consumption Value by Application (2019-2030)
8.3 Asia-Pacific Anti-tumor Drug Market Size by Region
8.3.1 Asia-Pacific Anti-tumor Drug Consumption Value by Region (2019-2030)
8.3.2 China Anti-tumor Drug Market Size and Forecast (2019-2030)
8.3.3 Japan Anti-tumor Drug Market Size and Forecast (2019-2030)
8.3.4 South Korea Anti-tumor Drug Market Size and Forecast (2019-2030)
8.3.5 India Anti-tumor Drug Market Size and Forecast (2019-2030)
8.3.6 Southeast Asia Anti-tumor Drug Market Size and Forecast (2019-2030)
8.3.7 Australia Anti-tumor Drug Market Size and Forecast (2019-2030)
9 South America
9.1 South America Anti-tumor Drug Consumption Value by Type (2019-2030)
9.2 South America Anti-tumor Drug Consumption Value by Application (2019-2030)
9.3 South America Anti-tumor Drug Market Size by Country
9.3.1 South America Anti-tumor Drug Consumption Value by Country (2019-2030)
9.3.2 Brazil Anti-tumor Drug Market Size and Forecast (2019-2030)
9.3.3 Argentina Anti-tumor Drug Market Size and Forecast (2019-2030)
10 Middle East & Africa
10.1 Middle East & Africa Anti-tumor Drug Consumption Value by Type (2019-2030)
10.2 Middle East & Africa Anti-tumor Drug Consumption Value by Application (2019-2030)
10.3 Middle East & Africa Anti-tumor Drug Market Size by Country
10.3.1 Middle East & Africa Anti-tumor Drug Consumption Value by Country (2019-2030)
10.3.2 Turkey Anti-tumor Drug Market Size and Forecast (2019-2030)
10.3.3 Saudi Arabia Anti-tumor Drug Market Size and Forecast (2019-2030)
10.3.4 UAE Anti-tumor Drug Market Size and Forecast (2019-2030)
11 Market Dynamics
11.1 Anti-tumor Drug Market Drivers
11.2 Anti-tumor Drug Market Restraints
11.3 Anti-tumor Drug Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 Industry Chain Analysis
12.1 Anti-tumor Drug Industry Chain
12.2 Anti-tumor Drug Upstream Analysis
12.3 Anti-tumor Drug Midstream Analysis
12.4 Anti-tumor Drug Downstream Analysis
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer

List of Tables
Table 1. Global Anti-tumor Drug Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Table 2. Global Anti-tumor Drug Consumption Value by Application, (USD Million), 2019 & 2023 & 2030
Table 3. Global Anti-tumor Drug Consumption Value by Region (2019-2024) & (USD Million)
Table 4. Global Anti-tumor Drug Consumption Value by Region (2025-2030) & (USD Million)
Table 5. Roche Company Information, Head Office, and Major Competitors
Table 6. Roche Major Business
Table 7. Roche Anti-tumor Drug Product and Solutions
Table 8. Roche Anti-tumor Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 9. Roche Recent Developments and Future Plans
Table 10. Novartis Company Information, Head Office, and Major Competitors
Table 11. Novartis Major Business
Table 12. Novartis Anti-tumor Drug Product and Solutions
Table 13. Novartis Anti-tumor Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 14. Novartis Recent Developments and Future Plans
Table 15. Celgene Company Information, Head Office, and Major Competitors
Table 16. Celgene Major Business
Table 17. Celgene Anti-tumor Drug Product and Solutions
Table 18. Celgene Anti-tumor Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 19. Celgene Recent Developments and Future Plans
Table 20. Bristol-Myers Squibb Company Information, Head Office, and Major Competitors
Table 21. Bristol-Myers Squibb Major Business
Table 22. Bristol-Myers Squibb Anti-tumor Drug Product and Solutions
Table 23. Bristol-Myers Squibb Anti-tumor Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 24. Bristol-Myers Squibb Recent Developments and Future Plans
Table 25. Amgen Company Information, Head Office, and Major Competitors
Table 26. Amgen Major Business
Table 27. Amgen Anti-tumor Drug Product and Solutions
Table 28. Amgen Anti-tumor Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 29. Amgen Recent Developments and Future Plans
Table 30. Johnson & Johnson Company Information, Head Office, and Major Competitors
Table 31. Johnson & Johnson Major Business
Table 32. Johnson & Johnson Anti-tumor Drug Product and Solutions
Table 33. Johnson & Johnson Anti-tumor Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 34. Johnson & Johnson Recent Developments and Future Plans
Table 35. Pfizer Company Information, Head Office, and Major Competitors
Table 36. Pfizer Major Business
Table 37. Pfizer Anti-tumor Drug Product and Solutions
Table 38. Pfizer Anti-tumor Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 39. Pfizer Recent Developments and Future Plans
Table 40. Takeda Company Information, Head Office, and Major Competitors
Table 41. Takeda Major Business
Table 42. Takeda Anti-tumor Drug Product and Solutions
Table 43. Takeda Anti-tumor Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 44. Takeda Recent Developments and Future Plans
Table 45. Eli Lilly Company Information, Head Office, and Major Competitors
Table 46. Eli Lilly Major Business
Table 47. Eli Lilly Anti-tumor Drug Product and Solutions
Table 48. Eli Lilly Anti-tumor Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 49. Eli Lilly Recent Developments and Future Plans
Table 50. AstraZeneca Company Information, Head Office, and Major Competitors
Table 51. AstraZeneca Major Business
Table 52. AstraZeneca Anti-tumor Drug Product and Solutions
Table 53. AstraZeneca Anti-tumor Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 54. AstraZeneca Recent Developments and Future Plans
Table 55. Astellas Company Information, Head Office, and Major Competitors
Table 56. Astellas Major Business
Table 57. Astellas Anti-tumor Drug Product and Solutions
Table 58. Astellas Anti-tumor Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 59. Astellas Recent Developments and Future Plans
Table 60. Merck & Co Company Information, Head Office, and Major Competitors
Table 61. Merck & Co Major Business
Table 62. Merck & Co Anti-tumor Drug Product and Solutions
Table 63. Merck & Co Anti-tumor Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 64. Merck & Co Recent Developments and Future Plans
Table 65. Sanofi Company Information, Head Office, and Major Competitors
Table 66. Sanofi Major Business
Table 67. Sanofi Anti-tumor Drug Product and Solutions
Table 68. Sanofi Anti-tumor Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 69. Sanofi Recent Developments and Future Plans
Table 70. Bayer Company Information, Head Office, and Major Competitors
Table 71. Bayer Major Business
Table 72. Bayer Anti-tumor Drug Product and Solutions
Table 73. Bayer Anti-tumor Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 74. Bayer Recent Developments and Future Plans
Table 75. Biogen Idec Company Information, Head Office, and Major Competitors
Table 76. Biogen Idec Major Business
Table 77. Biogen Idec Anti-tumor Drug Product and Solutions
Table 78. Biogen Idec Anti-tumor Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 79. Biogen Idec Recent Developments and Future Plans
Table 80. Eisai Company Information, Head Office, and Major Competitors
Table 81. Eisai Major Business
Table 82. Eisai Anti-tumor Drug Product and Solutions
Table 83. Eisai Anti-tumor Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 84. Eisai Recent Developments and Future Plans
Table 85. Teva Company Information, Head Office, and Major Competitors
Table 86. Teva Major Business
Table 87. Teva Anti-tumor Drug Product and Solutions
Table 88. Teva Anti-tumor Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 89. Teva Recent Developments and Future Plans
Table 90. Otsuka Company Information, Head Office, and Major Competitors
Table 91. Otsuka Major Business
Table 92. Otsuka Anti-tumor Drug Product and Solutions
Table 93. Otsuka Anti-tumor Drug Revenue (USD Million), Gross Margin and Market Share (2019-2024)
Table 94. Otsuka Recent Developments and Future Plans
Table 95. Global Anti-tumor Drug Revenue (USD Million) by Players (2019-2024)
Table 96. Global Anti-tumor Drug Revenue Share by Players (2019-2024)
Table 97. Breakdown of Anti-tumor Drug by Company Type (Tier 1, Tier 2, and Tier 3)
Table 98. Market Position of Players in Anti-tumor Drug, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2023
Table 99. Head Office of Key Anti-tumor Drug Players
Table 100. Anti-tumor Drug Market: Company Product Type Footprint
Table 101. Anti-tumor Drug Market: Company Product Application Footprint
Table 102. Anti-tumor Drug New Market Entrants and Barriers to Market Entry
Table 103. Anti-tumor Drug Mergers, Acquisition, Agreements, and Collaborations
Table 104. Global Anti-tumor Drug Consumption Value (USD Million) by Type (2019-2024)
Table 105. Global Anti-tumor Drug Consumption Value Share by Type (2019-2024)
Table 106. Global Anti-tumor Drug Consumption Value Forecast by Type (2025-2030)
Table 107. Global Anti-tumor Drug Consumption Value by Application (2019-2024)
Table 108. Global Anti-tumor Drug Consumption Value Forecast by Application (2025-2030)
Table 109. North America Anti-tumor Drug Consumption Value by Type (2019-2024) & (USD Million)
Table 110. North America Anti-tumor Drug Consumption Value by Type (2025-2030) & (USD Million)
Table 111. North America Anti-tumor Drug Consumption Value by Application (2019-2024) & (USD Million)
Table 112. North America Anti-tumor Drug Consumption Value by Application (2025-2030) & (USD Million)
Table 113. North America Anti-tumor Drug Consumption Value by Country (2019-2024) & (USD Million)
Table 114. North America Anti-tumor Drug Consumption Value by Country (2025-2030) & (USD Million)
Table 115. Europe Anti-tumor Drug Consumption Value by Type (2019-2024) & (USD Million)
Table 116. Europe Anti-tumor Drug Consumption Value by Type (2025-2030) & (USD Million)
Table 117. Europe Anti-tumor Drug Consumption Value by Application (2019-2024) & (USD Million)
Table 118. Europe Anti-tumor Drug Consumption Value by Application (2025-2030) & (USD Million)
Table 119. Europe Anti-tumor Drug Consumption Value by Country (2019-2024) & (USD Million)
Table 120. Europe Anti-tumor Drug Consumption Value by Country (2025-2030) & (USD Million)
Table 121. Asia-Pacific Anti-tumor Drug Consumption Value by Type (2019-2024) & (USD Million)
Table 122. Asia-Pacific Anti-tumor Drug Consumption Value by Type (2025-2030) & (USD Million)
Table 123. Asia-Pacific Anti-tumor Drug Consumption Value by Application (2019-2024) & (USD Million)
Table 124. Asia-Pacific Anti-tumor Drug Consumption Value by Application (2025-2030) & (USD Million)
Table 125. Asia-Pacific Anti-tumor Drug Consumption Value by Region (2019-2024) & (USD Million)
Table 126. Asia-Pacific Anti-tumor Drug Consumption Value by Region (2025-2030) & (USD Million)
Table 127. South America Anti-tumor Drug Consumption Value by Type (2019-2024) & (USD Million)
Table 128. South America Anti-tumor Drug Consumption Value by Type (2025-2030) & (USD Million)
Table 129. South America Anti-tumor Drug Consumption Value by Application (2019-2024) & (USD Million)
Table 130. South America Anti-tumor Drug Consumption Value by Application (2025-2030) & (USD Million)
Table 131. South America Anti-tumor Drug Consumption Value by Country (2019-2024) & (USD Million)
Table 132. South America Anti-tumor Drug Consumption Value by Country (2025-2030) & (USD Million)
Table 133. Middle East & Africa Anti-tumor Drug Consumption Value by Type (2019-2024) & (USD Million)
Table 134. Middle East & Africa Anti-tumor Drug Consumption Value by Type (2025-2030) & (USD Million)
Table 135. Middle East & Africa Anti-tumor Drug Consumption Value by Application (2019-2024) & (USD Million)
Table 136. Middle East & Africa Anti-tumor Drug Consumption Value by Application (2025-2030) & (USD Million)
Table 137. Middle East & Africa Anti-tumor Drug Consumption Value by Country (2019-2024) & (USD Million)
Table 138. Middle East & Africa Anti-tumor Drug Consumption Value by Country (2025-2030) & (USD Million)
Table 139. Anti-tumor Drug Raw Material
Table 140. Key Suppliers of Anti-tumor Drug Raw Materials
List of Figures
Figure 1. Anti-tumor Drug Picture
Figure 2. Global Anti-tumor Drug Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 3. Global Anti-tumor Drug Consumption Value Market Share by Type in 2023
Figure 4. Cytotoxic Drugs
Figure 5. Non-cytotoxic Drugs
Figure 6. Global Anti-tumor Drug Consumption Value by Type, (USD Million), 2019 & 2023 & 2030
Figure 7. Anti-tumor Drug Consumption Value Market Share by Application in 2023
Figure 8. Alkylating Agents Picture
Figure 9. Anti-Metabolism Drugs Picture
Figure 10. Platinum Antineoplastic Agents Picture
Figure 11. Anthracycline Antitumor Drugs Picture
Figure 12. Microtubule Stabilizer Picture
Figure 13. Endocrine Therapy Drugs Picture
Figure 14. Immunotherapy Drugs Picture
Figure 15. Gene Therapy Drugs Picture
Figure 16. Targeted Antineoplastic Drugs Picture
Figure 17. Global Anti-tumor Drug Consumption Value, (USD Million): 2019 & 2023 & 2030
Figure 18. Global Anti-tumor Drug Consumption Value and Forecast (2019-2030) & (USD Million)
Figure 19. Global Market Anti-tumor Drug Consumption Value (USD Million) Comparison by Region (2019 & 2023 & 2030)
Figure 20. Global Anti-tumor Drug Consumption Value Market Share by Region (2019-2030)
Figure 21. Global Anti-tumor Drug Consumption Value Market Share by Region in 2023
Figure 22. North America Anti-tumor Drug Consumption Value (2019-2030) & (USD Million)
Figure 23. Europe Anti-tumor Drug Consumption Value (2019-2030) & (USD Million)
Figure 24. Asia-Pacific Anti-tumor Drug Consumption Value (2019-2030) & (USD Million)
Figure 25. South America Anti-tumor Drug Consumption Value (2019-2030) & (USD Million)
Figure 26. Middle East and Africa Anti-tumor Drug Consumption Value (2019-2030) & (USD Million)
Figure 27. Global Anti-tumor Drug Revenue Share by Players in 2023
Figure 28. Anti-tumor Drug Market Share by Company Type (Tier 1, Tier 2 and Tier 3) in 2023
Figure 29. Global Top 3 Players Anti-tumor Drug Market Share in 2023
Figure 30. Global Top 6 Players Anti-tumor Drug Market Share in 2023
Figure 31. Global Anti-tumor Drug Consumption Value Share by Type (2019-2024)
Figure 32. Global Anti-tumor Drug Market Share Forecast by Type (2025-2030)
Figure 33. Global Anti-tumor Drug Consumption Value Share by Application (2019-2024)
Figure 34. Global Anti-tumor Drug Market Share Forecast by Application (2025-2030)
Figure 35. North America Anti-tumor Drug Consumption Value Market Share by Type (2019-2030)
Figure 36. North America Anti-tumor Drug Consumption Value Market Share by Application (2019-2030)
Figure 37. North America Anti-tumor Drug Consumption Value Market Share by Country (2019-2030)
Figure 38. United States Anti-tumor Drug Consumption Value (2019-2030) & (USD Million)
Figure 39. Canada Anti-tumor Drug Consumption Value (2019-2030) & (USD Million)
Figure 40. Mexico Anti-tumor Drug Consumption Value (2019-2030) & (USD Million)
Figure 41. Europe Anti-tumor Drug Consumption Value Market Share by Type (2019-2030)
Figure 42. Europe Anti-tumor Drug Consumption Value Market Share by Application (2019-2030)
Figure 43. Europe Anti-tumor Drug Consumption Value Market Share by Country (2019-2030)
Figure 44. Germany Anti-tumor Drug Consumption Value (2019-2030) & (USD Million)
Figure 45. France Anti-tumor Drug Consumption Value (2019-2030) & (USD Million)
Figure 46. United Kingdom Anti-tumor Drug Consumption Value (2019-2030) & (USD Million)
Figure 47. Russia Anti-tumor Drug Consumption Value (2019-2030) & (USD Million)
Figure 48. Italy Anti-tumor Drug Consumption Value (2019-2030) & (USD Million)
Figure 49. Asia-Pacific Anti-tumor Drug Consumption Value Market Share by Type (2019-2030)
Figure 50. Asia-Pacific Anti-tumor Drug Consumption Value Market Share by Application (2019-2030)
Figure 51. Asia-Pacific Anti-tumor Drug Consumption Value Market Share by Region (2019-2030)
Figure 52. China Anti-tumor Drug Consumption Value (2019-2030) & (USD Million)
Figure 53. Japan Anti-tumor Drug Consumption Value (2019-2030) & (USD Million)
Figure 54. South Korea Anti-tumor Drug Consumption Value (2019-2030) & (USD Million)
Figure 55. India Anti-tumor Drug Consumption Value (2019-2030) & (USD Million)
Figure 56. Southeast Asia Anti-tumor Drug Consumption Value (2019-2030) & (USD Million)
Figure 57. Australia Anti-tumor Drug Consumption Value (2019-2030) & (USD Million)
Figure 58. South America Anti-tumor Drug Consumption Value Market Share by Type (2019-2030)
Figure 59. South America Anti-tumor Drug Consumption Value Market Share by Application (2019-2030)
Figure 60. South America Anti-tumor Drug Consumption Value Market Share by Country (2019-2030)
Figure 61. Brazil Anti-tumor Drug Consumption Value (2019-2030) & (USD Million)
Figure 62. Argentina Anti-tumor Drug Consumption Value (2019-2030) & (USD Million)
Figure 63. Middle East and Africa Anti-tumor Drug Consumption Value Market Share by Type (2019-2030)
Figure 64. Middle East and Africa Anti-tumor Drug Consumption Value Market Share by Application (2019-2030)
Figure 65. Middle East and Africa Anti-tumor Drug Consumption Value Market Share by Country (2019-2030)
Figure 66. Turkey Anti-tumor Drug Consumption Value (2019-2030) & (USD Million)
Figure 67. Saudi Arabia Anti-tumor Drug Consumption Value (2019-2030) & (USD Million)
Figure 68. UAE Anti-tumor Drug Consumption Value (2019-2030) & (USD Million)
Figure 69. Anti-tumor Drug Market Drivers
Figure 70. Anti-tumor Drug Market Restraints
Figure 71. Anti-tumor Drug Market Trends
Figure 72. Porters Five Forces Analysis
Figure 73. Manufacturing Cost Structure Analysis of Anti-tumor Drug in 2023
Figure 74. Manufacturing Process Analysis of Anti-tumor Drug
Figure 75. Anti-tumor Drug Industrial Chain
Figure 76. Methodology
Figure 77. Research Process and Data Source

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Nuclear Medicine Cyclotron Systems Market Report, History and Forecast 2018-2029

Published: 11-Jan-2024        Price: US 3350 Onwards        Pages: 118

The global Nuclear Medicine Cyclotron Systems market was valued at US$ 220.85 million in 2022 and will reach US$ 283.75 million by the end of 2029, growing at a CAGR of 4.38% during 2023-2029. Asia-Pacific market for Nuclear Medicine Cyclotron Systems was valued at $ 61.16 million in 2022 and will reach $ 104.22 million by 2029, at a CAGR of 5.84% during the forecast period of 2023 through 2029. Report Scope This report aims to provide a comprehensive presentation of the glo......

Global Non-imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 95

The global Non-imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estim......

Global Imaging Diagnostic Catheter Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 90

The global Imaging Diagnostic Catheter market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during The next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, The chemical drug market is estimated......

Global PCR Equipment Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 77

The global PCR Equipment market was valued at US$ 806 million in 2023 and is anticipated to reach US$ 1230.7 million by 2030, witnessing a CAGR of 6.7% during The forecast period 2024-2030. PCR (Polymerase Chain Reaction) equipment is widely used in molecular biology and genetics research for amplifying DNA and RNA sequences. The market for PCR equipment is influenced by several key drivers. Here are some of The significant market drivers: Advancements in Research and Diagnost......

Global Disposable Sterile Syringes and Needles Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 109

The global Disposable Sterile Syringes and Needles market was valued at US$ 404.4 million in 2023 and is anticipated to reach US$ 539.1 million by 2030, witnessing a CAGR of 2.1% during The forecast period 2024-2030. North American market for Disposable Sterile Syringes and Needles is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Disposable Sterile Syringes and N......

Global Orthopaedic Power Tools Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 106

The global Orthopaedic Power Tools market was valued at US$ 463.3 million in 2023 and is anticipated to reach US$ 746.5 million by 2030, witnessing a CAGR of 7.3% during The forecast period 2024-2030. North American market for Orthopaedic Power Tools is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Orthopaedic Power Tools is estimated to increase from $ million i......

Global Cerebrospinal Fluid Management Devices Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 86

The global Cerebrospinal Fluid Management Devices market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Cerebrospinal Fluid Management Devices is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Cerebrospinal Fluid Management Devices is estimate......

Global CAD & CAM Milling Burs Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 79

The global CAD & CAM Milling Burs market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for CAD & CAM Milling Burs is estimated to increase from $ million in 2023 to reach $ ......

Global Artificial Teeth Market Research Report 2024

Published: 10-Jan-2024        Price: US 2900 Onwards        Pages: 98

The global Artificial Teeth market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during The forecast period 2024-2030. North American market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during The forecast period of 2024 through 2030. Asia-Pacific market for Artificial Teeth is estimated to increase from $ million in 2023 to reach $ million by 2030, a......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs